Menu

Infinity Pharmaceuticals, Inc. INFI

Full chart Compare
Set alert

Price alert · INFI

All alert types
0.01 +0.01

Day range unavailable

52-week range unavailable

Revenue & Expenses

Other Income → Expenses: $475.00KIncome Tax Benefit → Expenses: $1.11MExpenses → Selling, General & Admin: $13.46MExpenses → Research & Development: $32.41MGross Profit → Expenses: $1.03MRevenue → Gross Profit: $1.03MRevenue → Cost of Revenue: $1.56MNet Loss → Expenses: $43.26MOther Income$475.00KIncome Tax Benefit$1.11MGross Profit$1.03MNet Loss$43.26MCost of Revenue$1.56MExpenses$45.87MSelling, General & Admin$13.46MResearch & Development$32.41MRevenue$2.59M

Latest period ending Dec 31, 2022 · select a line to chart its full history

INFI annual income statement
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
2.59M1.86M1.72M3.05M22.15M
2.59M1.86M1.72M3.05M22.15M
-44.84M-45.08M-38.50M-45.66M-11.93M
-44.37M-45.26M-40.49M-47.06M-11.25M
-0.50-0.53-0.68-0.83-0.20
INFI annual balance sheet
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
38.47M80.73M28.59M22.26M48.62M
42.15M84.78M39.32M49.01M60.22M
61.20M63.21M62.31M41.29M7.76M
324.00K917.00K1.44M1.93M0
-19.05M21.57M-22.99M7.73M52.46M
INFI annual cash flow
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
-42.43M-40.62M-35.74M-41.53M-4.71M
-55.00K5.49M14.63M-12.24M13.10M
73.00K87.11M27.44M27.73M5.62M
-17.00K-11.00K-43.00K-2.33M0
-42.41M51.98M6.33M-26.04M14.01M